Annexin IV is Differentially Expressed in Clear Cell Carcinoma of the Ovary

被引：25

作者：

Miao, Yi ^{[1
]}

Cai, Bin ^{[1
]}

Liu, Ling ^{[1
,2
,3
]}

Yang, Yixia ^{[1
]}

Wan, Xiaoping ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Afiliated Peoples Hosp 1, Shanghai 200080, Peoples R China

[2] Univ Toronto, Dept Med, Toronto, ON, Canada

[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2009年 / 19卷 / 09期

关键词：

Clear cell carcinoma of the ovary; Gene expression profiling; Annexin IV; GENE-EXPRESSION; CLINICAL CHARACTERISTICS; ENDOMETRIAL CANCER; RESISTANCE; TUMORS; CLASSIFICATION; IDENTIFICATION; LYMPHOMA; PROTEINS;

D O I：

10.1111/IGC.0b013e3181a844c8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objective: To investigate the genes that were differentially expressed between clear cell carcinoma (CCC) and serous carcinoma (SAC) of the ovary with complementary DNA microarray. Methods: Complementary DNA microarray was carried out in 8 CCCs and 8 SACs of the ovary. Differentially expressed genes were identified and verified by real-time polymerase chain reaction. The expression of the protein was also verified with immnunohistochemistry and Western blot in cells and tissues of ovarian CCC. Results: Comparison of the gene expression profiling identified 21 genes with more than 2-fold different expression between CCC and SAC of the ovary. The up-regulated and down-regulated genes were 9 and 12, respectively. The verification of Annexin IV in the cell line and tissues was in accordance with the result of the microarray. Conclusions: The complementary DNA microarray technique is a feasible way to explore the difference of the gene expression profiling between the 2 types of ovarian carcinoma. The overexpression of Annexin IV may be an ovarian CCC-specific molecular marker.

引用

页码：1545 / 1549

页数：5

共 29 条

[21] Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [J].

Sorlie, T ;

Perou, CM ;

Tibshirani, R ;

Aas, T ;

Geisler, S ;

Johnsen, H ;

Hastie, T ;

Eisen, MB ;

van de Rijn, M ;

Jeffrey, SS ;

Thorsen, T ;

Quist, H ;

Matese, JC ;

Brown, PO ;

Botstein, D ;

Lonning, PE ;

Borresen-Dale, AL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10869-10874

[22] Proteins associated with cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels [J].

Stewart, JJ ;

White, JT ;

Yan, XW ;

Collins, S ;

Drescher, CW ;

Urban, ND ;

Hood, L ;

Lin, BY .

MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (03) :433-443

[23]

Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO

[24]

2-5

[25] Expression profiling in ovarian clear cell carcinoma identification of hepatocyte nuclear factor-1β as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma [J].

Tsuchiya, A ;

Sakamoto, M ;

Yasuda, J ;

Chuma, M ;

Ohta, T ;

Ohki, M ;

Yasugi, T ;

Taketani, Y ;

Hirohashi, S .

AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (06) :2503-2512

[26] Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses [J].

Tsuda, H ;

Ito, YM ;

Ohashi, Y ;

Wong, KK ;

Hashiguchi, Y ;

Welch, WR ;

Berkowitz, RS ;

Birrer, MJ ;

Mok, SC .

CLINICAL CANCER RESEARCH, 2005, 11 (19) :6880-6888

[27] Gene expression profiling predicts clinical outcome of breast cancer [J].

van't Veer, LJ ;

Dai, HY ;

van de Vijver, MJ ;

He, YDD ;

Hart, AAM ;

Mao, M ;

Peterse, HL ;

van der Kooy, K ;

Marton, MJ ;

Witteveen, AT ;

Schreiber, GJ ;

Kerkhoven, RM ;

Roberts, C ;

Linsley, PS ;

Bernards, R ;

Friend, SH .

NATURE, 2002, 415 (6871) :530-536

[28] Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination [J].

Zimmermann, U ;

Balabanov, S ;

Giebel, J ;

Teller, S ;

Junker, H ;

Schmoll, D ;

Protzel, C ;

Scharf, C ;

Kleist, B ;

Walther, R .

CANCER LETTERS, 2004, 209 (01) :111-118

[29] Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer [J].

Zorn, KK ;

Bonome, T ;

Gangi, L ;

Chandramouli, GVR ;

Awtrey, CS ;

Gardner, GJ ;

Barrett, JC ;

Boyd, J ;

Birrer, MJ .

CLINICAL CANCER RESEARCH, 2005, 11 (18) :6422-6430

← 1 2 3 →